http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110038009-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6a6f422b091ba12ea61d4adbf1b0e8e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
filingDate 2019-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_515362ee2065e4eaade6d729b46bd70f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c40b2b72ab23a121c415b5d321d20cff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_298eba204e3d7f4f05fd80fe43423cb8
publicationDate 2019-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110038009-A
titleOfInvention Application of canagliflozin in the preparation of antitumor drugs
abstract The invention provides an application of canagliflozin in the preparation of anti-tumor drugs, especially in the preparation of drugs for treating solid tumors. Studies have shown that canagliflozin can significantly down-regulate the immune checkpoint protein PD-L1 in various tumor cells, and can effectively enhance the killing effect of T cells on tumor cells in the co-incubation model of T cells and tumor cells. , thereby expanding the clinical application of the chemical drug canagliflozin in tumor immunotherapy. The invention provides a new medical use for canagliflozin, and also provides new ideas and potential targets for the development of small molecule drugs based on PD-L1.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112439067-A
priorityDate 2019-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453324755
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID399680
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID60533
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64522
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID613842
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6524
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428545465
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73755215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24997615
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18566
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID246787

Total number of triples: 34.